(2-((tert-Butoxycarbonyl)amino)-7-fluorobenzo[d]thiazol-4-yl)boronic acid, 97%, 5g

4-Fluoro-2-(methylsulfonyl)aniline, 95.0%, 1g

(2S,4S)-Methyl 4-amino-1-benzoylpyrrolidine-2-carboxylate hydrochloride, 95%, 100mg

4-((4-methoxyphenyl)sulfonyl)butanoyl chloride, 95.0%, 1g

5-Ethynyl-dUTP, min. 95%, 100 mM in water, 50 µl, plastic packaging.

Ethyl 6-chloropyrazolo[1,5-a]pyridine-3-carboxylate, 95.0%, 100mg

butyl[(2,6-dichlorophenyl)methyl]amine, 95.0%, 2g

4,6-BIS((S)-4-(TERT-BUTYL)-4,5-DIHYDROOXAZOL-2-YL)DIBENZO[B,D]FURAN, 95%, 250mg

(S)-N-(2,6-Dimethylphenyl)piperidine-2-carboxamide, 95.0%, 5g

3-(Pyridin-4-yl)pentane-1,5-diol, 98.0%, 100mg

1,5-Dichloro-3-methyl-2-nitrobenzene, 95.0%, 1g

2-Amino-6,7,8,9-tetrahydro-5H-benzo[7]annulen-5-one, 95.0%, 1g

5-Chloropentan-2-ol, 95%, 250mg